Genetic identification of familial hypercholesterolemia within a single US health care system

被引：308

作者：

Abul-Husn, Noura S. ^{[1
]}

Manickam, Kandamurugu ^{[2
]}

Jones, Laney K. ^{[2
]}

Wright, Eric A. ^{[2
]}

Hartzel, Dustin N. ^{[2
]}

Gonzaga-Jauregui, Claudia ^{[1
]}

O'Dushlaine, Colm ^{[1
]}

Leader, Joseph B. ^{[2
]}

Kirchner, H. Lester ^{[2
]}

Lindbuchler, D'Andra M. ^{[2
]}

Barr, Marci L. ^{[2
]}

Giovanni, Monica A. ^{[2
]}

Ritchie, Marylyn D. ^{[2
]}

Overton, John D. ^{[1
]}

Reid, Jeffrey G. ^{[1
]}

Metpally, Raghu P. R. ^{[2
]}

Wardeh, Amr H. ^{[2
]}

Borecki, Ingrid B. ^{[1
]}

Yancopoulos, George D. ^{[1
]}

Baras, Aris ^{[1
]}

Shuldiner, Alan R. ^{[1
]}

Gottesman, Omri ^{[1
]}

Ledbetter, David H. ^{[2
]}

Carey, David J. ^{[2
]}

Dewey, Frederick E. ^{[1
]}

Murray, Michael F. ^{[2
]}

机构：

[1] Regeneron Genet Ctr, Tarrytown, NY 10591 USA

[2] Geisinger Hlth Syst, Danville, PA 17822 USA

来源：

SCIENCE | 2016年 / 354卷 / 6319期

关键词：

ASSOCIATION EXPERT PANEL; GENERAL-POPULATION; PREVALENCE; MANAGEMENT; DIAGNOSIS; RECOMMENDATIONS; CHOLESTEROL; VARIANTS; GENOME; GUIDELINES;

D O I：

10.1126/science.aaf7000

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Familial hypercholesterolemia (FH) remains underdiagnosed despite widespread cholesterol screening. Exome sequencing and electronic health record (EHR) data of 50,726 individuals were used to assess the prevalence and clinical impact of FH-associated genomic variants in the Geisinger Health System. The estimated FH prevalence was 1: 256 in unselected participants and 1: 118 in participants ascertained via the cardiac catheterization laboratory. FH variant carriers had significantly increased risk of coronary artery disease. Only 24% of carriers met EHR-based presequencing criteria for probable or definite FH diagnosis. Active statin use was identified in 58% of carriers; 46% of statin-treated carriers had a low-density lipoprotein cholesterol level below 100 mg/dl. Thus, we find that genomic screening can prompt the diagnosis of FH patients, most of whom are receiving inadequate lipid-lowering therapy.

引用

页数：7

共 48 条

[11] A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Cingolani, Pablo
Platts, Adrian
Wang, Le Lily
Coon, Melissa
Tung Nguyen
Wang, Luan
Land, Susan J.
Lu, Xiangyi
Ruden, Douglas M.
[J]. FLY, 2012, 6 (02) : 80 - 92
[12] Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
Civeira, F
[J]. ATHEROSCLEROSIS, 2004, 173 (01) : 55 - 68
[13] Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR Study
Dewey, Frederick E.
Murray, Michael F.
Overton, John D.
Habegger, Lukas
Leader, Joseph B.
Fetterolf, Samantha N.
O'Dushlaine, Colm
Van Hout, Cristopher V.
Staples, Jeffrey
Gonzaga-Jauregui, Claudia
Metpally, Raghu
Pendergrass, Sarah A.
Giovanni, Monica A.
Kirchner, H. Lester
Balasubramanian, Suganthi
Abul-Husn, Noura S.
Hartzel, Dustin N.
Lavage, Daniel R.
Kost, Korey A.
Packer, Jonathan S.
Lopez, Alexander E.
Penn, John
Mukherjee, Semanti
Gosalia, Nehal
Kanagaraj, Manoj
Li, Alexander H.
Mitnaul, Lyndon J.
Adams, Lance J.
Person, Thomas N.
Praveen, Kavita
Marcketta, Anthony
Lebo, Matthew S.
Austin-Tse, Christina A.
Mason-Suares, Heather M.
Bruse, Shannon
Mellis, Scott
Phillips, Robert
Stahl, Neil
Murphy, Andrew
Economides, Aris
Skelding, Kimberly A.
Still, Christopher D.
Elmore, James R.
Borecki, Ingrid B.
Yancopoulos, George D.
Davis, F. Daniel
Faucett, William A.
Gottesman, Omri
Ritchie, Marylyn D.
Shuldiner, Alan R.
[J]. SCIENCE, 2016, 354 (6319)
[14] Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, Frederick F.
Gusarova, Viktoria
O'Dushlaine, Colm
Gottesman, Omri
Trejos, Jesus
Hunt, Charleen
Van Hout, Cristopher V.
Habegger, Lukas
Buckler, David
Lai, Ka-Man V.
Leader, Joseph B.
Murray, Michael F.
Ritchie, Marylyn D.
Kirchner, H. Lester
Ledbetter, David H.
Penn, John
Lopez, Alexander
Borecki, Ingrid B.
Overton, John D.
Reid, Jeffrey G.
Carey, David J.
Murphy, Andrew J.
Yancopoulos, George D.
Baras, Aris
Gromada, Jesper
Shuldiner, Alan R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (12) : 1123 - 1133
[15] The Agenda for Familial Hypercholesterolemia A Scientific Statement From the American Heart Association
Gidding, Samuel S.
Champagne, Mary Ann
de Ferranti, Sarah D.
Defesche, Joep
Ito, Matthew K.
Knowles, Joshua W.
McCrindle, Brian
Raal, Frederick
Rader, Daniel
Santos, Raul D.
Lopes-Virella, Maria
Watts, Gerald F.
Wierzbicki, Anthony S.
[J]. CIRCULATION, 2015, 132 (22) : 2167 - 2192
[16] Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001
[17] HYPERLIPIDEMIA IN CORONARY HEART-DISEASE .2. GENETIC ANALYSIS OF LIPID-LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
GOLDSTEIN, JL
SCHROTT, HG
HAZZARD, WR
BIRMAN, EL
MOTULSKY, AG
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) : 1544 - 1568
[18] ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, Robert C.
Berg, Jonathan S.
Grody, Wayne W.
Kalia, Sarah S.
Korf, Bruce R.
Martin, Christa L.
McGuire, Amy L.
Nussbaum, Robert L.
O'Daniel, Julianne M.
Ormond, Kelly E.
Rehm, Heidi L.
Watson, Michael S.
Williams, Marc S.
Biesecker, Leslie G.
[J]. GENETICS IN MEDICINE, 2013, 15 (07) : 565 - 574
[19] A solution to the problem of separation in logistic regression
Heinze, G
Schemper, M
[J]. STATISTICS IN MEDICINE, 2002, 21 (16) : 2409 - 2419
[20] Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Hopkins, Paul N.
Toth, Peter P.
Ballantyne, Christie M.
Rader, Daniel J.
[J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) : S9 - S17

← 1 2 3 4 5 →